Not applicableLooking for participantsNCT03344016What this trial is testingMulticenter Pheochromocytoma and Paraganglioma EvaluationWho this might be right forPheochromocytomaParaganglioma Felix Beuschlein 1,148
Large-scale testing (Phase 3)Study completedNCT00442533What this trial is testingSafety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Radio Isotope Therapy of America 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135What this trial is testingStudy to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLsWho this might be right forGastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma Advanced Accelerator Applications 11
Not applicableUnknownNCT05158712What this trial is testingGenetic Factors and Pheochromocytomas in Neoplasia Type 2Who this might be right forNeoplasiaPheochromocytoma Assistance Publique Hopitaux De Marseille 14
Testing effectiveness (Phase 2)Ended earlyNCT04187404What this trial is testingA Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/ParagangliomaWho this might be right forAdrenocortical CarcinomaPheochromocytomaParaganglioma Enterome 70
Not applicableEnrolling By InvitationNCT07182175What this trial is testingComparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal TumorsWho this might be right forPrimary AldosteronismAdrenal TumorCushing s Syndrome+1 more Peking University First Hospital 150
Not applicableWithdrawnNCT04770831What this trial is testingPatients Who Receive 131 I-MIBGWho this might be right forBrain and Nervous System Wake Forest University Health Sciences
Not applicableNot Yet RecruitingNCT04788927What this trial is testingDevelopment of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort StudyWho this might be right forParagangliomaPheochromocytomaGenetic Predisposition to Disease+4 more Rigshospitalet, Denmark 400
Testing effectiveness (Phase 2)Study completedNCT03008369What this trial is testingLenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by SurgeryWho this might be right forMalignant Adrenal Gland PheochromocytomaMalignant ParagangliomaMetastatic Adrenal Gland Pheochromocytoma Mayo Clinic 3
Not applicableStudy completedNCT01022515What this trial is testingSpecificity of Elevated Plasma EM66 Levels in PheochromocytomaWho this might be right forPheochromocytomaParagangliomaEssential Hypertension University Hospital, Rouen 60
Not applicableLooking for participantsNCT06444607What this trial is testingHereditary Pheochromocytoma Assessment of Tumour ImmunologiesWho this might be right forPheochromocytomaParaganglioma Radboud University Medical Center 200
Early research (Phase 1)Study completedNCT00339131What this trial is testingULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic CarcinoidWho this might be right forPheochromocytomaParagangliomaCarcinoid Molecular Insight Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)WithdrawnNCT04106843What this trial is testingRadioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine CancersWho this might be right forLocally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more M.D. Anderson Cancer Center
Not applicableActive Not RecruitingNCT03583528What this trial is testingDOTATOC PET/CT for Imaging NET PatientsWho this might be right forNeuroendocrine TumorsInsulinomaGastrinoma+13 more British Columbia Cancer Agency 800
Early research (Phase 1)Ended earlyNCT04895748What this trial is testingDFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other MalignanciesWho this might be right forCarcinoma, Renal Cell Novartis Pharmaceuticals 40
Not applicableStudy completedNCT05102058What this trial is testingMagnesium and Dexmedetomidine in PheochromocytomaWho this might be right forPhaeochromocytoma CrisisHemodynamic Instability Istanbul University 108
Testing effectiveness (Phase 2)Study completedNCT01152827What this trial is testingRAD001 in Pheochromocytoma or Nonfunctioning CarcinoidWho this might be right forPheochromocytomaExtra-adrenal ParagangliomaNon-functioning Carcinoid Seoul National University Hospital 33
Not applicableUnknownNCT06015061What this trial is testingPrediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL PatientsWho this might be right forPheochromocytoma, MetastaticUltrasonographyParaganglioma, Malignant+1 more Peking Union Medical College Hospital 20
Not applicableStudy completedNCT01676025What this trial is testingComparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic AdrenalectomyWho this might be right forAdrenal Disease Seoul National University Hospital 83
Testing effectiveness (Phase 2)Study completedNCT01967576What this trial is testingPhase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/ParagangliomaWho this might be right forPheochromocytomaParaganglioma National Cancer Institute (NCI) 14